The Untapped Potential
of Rainforest Medicinal Plants

Finally Delivering Results
in Cancer Treatment

Targeted Botanical Drugs
that Minimize Side Effects

Clinical Trials Are Under Way:
You Can Propel Them Further.

PROMISING CANDIDATES

  • Cordycepin

    Our most advanced drug candidate is Cordycepin, which is one of the best medicinal (fungi) mushrooms, known for numerous positive aspects in terms of pharmacological effects and considered to be safe. The main constituent of the extract derived from this fungus comprises a novel bio-metabolite called as Cordycepin (3′-deoxyadenosine), which has potent anticancer activities. We are developing Cordycepin as a treatment option for Continue Reading...

  • Amitosin

    Dr. Wilburn Henry Ferguson developed, refined, tested and administered an Amazon rainforest botanical extract named Amitosin, which is curative against several types of cancer. Amitosin was used as treatment for over 200 people with a variety of cancers by doctors, who reported positive results with no side effects. The extract is practically non-toxic and has an excellent safety profile. Amitosin is unique in that Continue Reading...

COMPANY NEWS

  • Leadership for Success
    0
    David Browning has been appointed President of Rainforest Pharmacal. With over 22 years of clinical drug development experience, including 175…
  • Cordycepin Acquired
    0
    Rainforest Pharmacal expands its portfolio with leukemia drug Cordycepin, acquired from Dr. Alexander Weis of Lipitek International. Its orphan drug…
  • Streamlined Operations
    0
    Mark Staples, Ph.D. is now Chief Scientific Officer. Bringing 25 years pharmaceutical project management background, he also has extensive technical…

Our Mission

We are dedicated to developing proprietary, safe and highly effective drugs from unique botanicals.

Most of the drugs on the market today were developed by synthesizing a plant design. The main focus of the company’s drug discovery effort is the development of effective anticancer botanical extracts into regulatory agency-approved, globally distributed, pharmaceutical drugs.

more info

Investment Opportunity

HIGH POTENTIAL ONCOLOGICAL DRUGS, ALREADY UNDERGOING TRIALS, LED BY SOLID MANAGEMENT

Rainforest Pharmacal is a unique opportunity, that enables investors to take part in medical breakthroughs with substantial human and economic impact. By helping clinical trials advance, they make science move forward.

more info